Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1072

1.

Preparation and X-ray structure of 2-iodoxybenzenesulfonic acid (IBS) - a powerful hypervalent iodine(V) oxidant.

Mironova IA, Postnikov PS, Yusubova RY, Yoshimura A, Wirth T, Zhdankin VV, Nemykin VN, Yusubov MS.

Beilstein J Org Chem. 2018 Jul 20;14:1854-1858. doi: 10.3762/bjoc.14.159. eCollection 2018.

PMID:
30112090
2.

Correlation between clinical and radiologic features of patients with Gerstmann-Sträussler-Scheinker syndrome (Pro102Leu).

Yoshimura M, Yuan JH, Higashi K, Yoshimura A, Arata H, Okubo R, Nakabeppu Y, Yoshiura T, Takashima H.

J Neurol Sci. 2018 Aug 15;391:15-21. doi: 10.1016/j.jns.2018.05.012. Epub 2018 May 17.

PMID:
30103963
3.

Temporal Regulation of ESCO2 Degradation by the MCM Complex, the CUL4-DDB1-VPRBP Complex, and the Anaphase-Promoting Complex.

Minamino M, Tei S, Negishi L, Kanemaki MT, Yoshimura A, Sutani T, Bando M, Shirahige K.

Curr Biol. 2018 Aug 1. pii: S0960-9822(18)30828-5. doi: 10.1016/j.cub.2018.06.037. [Epub ahead of print]

PMID:
30100344
4.

Nr4a Receptors Regulate Development and Death of Labile Treg Precursors to Prevent Generation of Pathogenic Self-Reactive Cells.

Sekiya T, Hibino S, Saeki K, Kanamori M, Takaki S, Yoshimura A.

Cell Rep. 2018 Aug 7;24(6):1627-1638.e6. doi: 10.1016/j.celrep.2018.07.008.

5.

Occult breast cancer may originate from ectopic breast tissue present in axillary lymph nodes.

Terada M, Adachi Y, Sawaki M, Hattori M, Yoshimura A, Naomi G, Kotani H, Iwase M, Kataoka A, Onishi S, Sugino K, Mori M, Horisawa N, Sasaki E, Yatabe Y, Iwata H.

Breast Cancer Res Treat. 2018 Jul 20. doi: 10.1007/s10549-018-4898-4. [Epub ahead of print] Review.

PMID:
30030707
6.

Multi-omics monitoring of drug response in rheumatoid arthritis in pursuit of molecular remission.

Tasaki S, Suzuki K, Kassai Y, Takeshita M, Murota A, Kondo Y, Ando T, Nakayama Y, Okuzono Y, Takiguchi M, Kurisu R, Miyazaki T, Yoshimoto K, Yasuoka H, Yamaoka K, Morita R, Yoshimura A, Toyoshiba H, Takeuchi T.

Nat Commun. 2018 Jul 16;9(1):2755. doi: 10.1038/s41467-018-05044-4.

7.

Genetic and phenotypic profile of 112 patients with X-linked Charcot-Marie-Tooth disease type 1.

Yuan JH, Sakiyama Y, Hashiguchi A, Ando M, Okamoto Y, Yoshimura A, Higuchi Y, Takashima H.

Eur J Neurol. 2018 Jul 11. doi: 10.1111/ene.13750. [Epub ahead of print]

PMID:
29998508
8.

Pulmonary pleomorphic carcinoma with pseudoprogression during nivolumab therapy and the usefulness of tumor markers: A case report.

Yoshimura A, Takumi C, Tsuji T, Hamashima R, Shiotsu S, Yuba T, Urata Y, Hiraoka N.

Clin Case Rep. 2018 May 29;6(7):1338-1341. doi: 10.1002/ccr3.1627. eCollection 2018 Jul.

9.

BK virus pneumonia following stem cell transplantation against diffuse large B-cell lymphoma.

Yoshimura A, Tsuji T, Kawaji Y, Hirakawa Y, Uchiyama H, Hiraoka N.

Respirol Case Rep. 2018 Jun 26;6(7):e00348. doi: 10.1002/rcr2.348. eCollection 2018 Oct.

10.

Reprogramming of Th1 cells into regulatory T cells through rewiring of the metabolic status.

Kanamori M, Nakatsukasa H, Ito M, Chikuma S, Yoshimura A.

Int Immunol. 2018 Jul 24;30(8):357-373. doi: 10.1093/intimm/dxy043.

PMID:
29982622
11.

Preparation, structure, and reactivity of bicyclic benziodazole: a new hypervalent iodine heterocycle.

Yoshimura A, Shea MT, Makitalo CL, Jarvi ME, Rohde GT, Saito A, Yusubov MS, Zhdankin VV.

Beilstein J Org Chem. 2018 May 8;14:1016-1020. doi: 10.3762/bjoc.14.87. eCollection 2018.

12.

Basic fibroblast growth factor increased glucocorticoid receptors in cortical neurons through MAP kinase pathway.

Numakawa T, Odaka H, Adachi N, Chiba S, Ooshima Y, Matsuno H, Nakajima S, Yoshimura A, Fumimoto K, Hirai Y, Kunugi H.

Neurochem Int. 2018 Sep;118:217-224. doi: 10.1016/j.neuint.2018.06.009. Epub 2018 Jun 26.

PMID:
29958871
13.

A randomized phase II study evaluating pyridoxine for the prevention of hand-foot syndrome associated with capecitabine therapy for advanced or metastatic breast cancer.

Toyama T, Yoshimura A, Hayashi T, Kobayashi N, Saito K, Tsuneizumi M, Sawaki M, Hattori M, Nakada T, Yokota I, Iwata H.

Breast Cancer. 2018 Jun 8. doi: 10.1007/s12282-018-0879-z. [Epub ahead of print]

PMID:
29948956
14.

The investigation study using a questionnaire about the employment of Japanese breast cancer patients.

Kotani H, Kataoka A, Sugino K, Iwase M, Onishi S, Adachi Y, Gondo N, Yoshimura A, Hattori M, Sawaki M, Iwata H.

Jpn J Clin Oncol. 2018 Aug 1;48(8):712-717. doi: 10.1093/jjco/hyy088.

PMID:
29939297
15.

NQO1 inhibits the TLR-dependent production of selective cytokines by promoting IκB-ζ degradation.

Kimura A, Kitajima M, Nishida K, Serada S, Fujimoto M, Naka T, Fujii-Kuriyama Y, Sakamato S, Ito T, Handa H, Tanaka T, Yoshimura A, Suzuki H.

J Exp Med. 2018 Aug 6;215(8):2197-2209. doi: 10.1084/jem.20172024. Epub 2018 Jun 22.

PMID:
29934320
16.

Radical Hydrophosphorylation of Alkynes with R2P(O)H Generating Alkenylphosphine Oxides: Scope and Limitations.

Huang T, Saga Y, Guo H, Yoshimura A, Ogawa A, Han LB.

J Org Chem. 2018 Aug 3;83(15):8743-8749. doi: 10.1021/acs.joc.8b01042. Epub 2018 Jun 28.

PMID:
29927246
17.

Effect of Japanese Kampo Medicine Therapy for Menopausal Symptoms after Treatment of Gynecological Malignancy.

Yoshimura A, Sawada K, Sasano T, Kuroda H, Kozasa K, Nakatsuka E, Nakamura K, Hashimoto K, Mabuchi S, Kimura T.

Obstet Gynecol Int. 2018 Apr 2;2018:9475919. doi: 10.1155/2018/9475919. eCollection 2018.

18.

Iodonium Salts as Benzyne Precursors.

Yoshimura A, Saito A, Zhdankin VV.

Chemistry. 2018 May 24. doi: 10.1002/chem.201802111. [Epub ahead of print] Review.

PMID:
29797627
19.

Regulation of Pathogenic T Helper 17 Cell Differentiation by Steroid Receptor Coactivator-3.

Tanaka K, Martinez GJ, Yan X, Long W, Ichiyama K, Chi X, Kim BS, Reynolds JM, Chung Y, Tanaka S, Liao L, Nakanishi Y, Yoshimura A, Zheng P, Wang X, Tian Q, Xu J, O'Malley BW, Dong C.

Cell Rep. 2018 May 22;23(8):2318-2329. doi: 10.1016/j.celrep.2018.04.088.

20.

Generation and application of human induced-stem cell memory T cells for adoptive immunotherapy.

Kondo T, Imura Y, Chikuma S, Hibino S, Omata-Mise S, Ando M, Akanuma T, Iizuka M, Sakai R, Morita R, Yoshimura A.

Cancer Sci. 2018 Jul;109(7):2130-2140. doi: 10.1111/cas.13648. Epub 2018 Jun 28.

21.

A mutation in transcription factor MAFB causes Focal Segmental Glomerulosclerosis with Duane Retraction Syndrome.

Sato Y, Tsukaguchi H, Morita H, Higasa K, Tran MTN, Hamada M, Usui T, Morito N, Horita S, Hayashi T, Takagi J, Yamaguchi I, Nguyen HT, Harada M, Inui K, Maruta Y, Inoue Y, Koiwa F, Sato H, Matsuda F, Ayabe S, Mizuno S, Sugiyama F, Takahashi S, Yoshimura A.

Kidney Int. 2018 Aug;94(2):396-407. doi: 10.1016/j.kint.2018.02.025. Epub 2018 May 18.

PMID:
29779709
22.

Cat scratch disease presenting as axillary lymphadenopathy and a palpable benign mammary nodule mimicking a carcinoma.

Marques LC, Pincerato K, Yoshimura AA, Andrade FEM, Barros ACSD.

Rev Soc Bras Med Trop. 2018 Mar-Apr;51(2):247-248. doi: 10.1590/0037-8682-0362-2016.

23.

One-pot synthesis of diaryliodonium salts from arenes and aryl iodides with Oxone-sulfuric acid.

Soldatova N, Postnikov P, Kukurina O, Zhdankin VV, Yoshimura A, Wirth T, Yusubov MS.

Beilstein J Org Chem. 2018 Apr 12;14:849-855. doi: 10.3762/bjoc.14.70. eCollection 2018.

24.

Mutations in COA7 cause spinocerebellar ataxia with axonal neuropathy.

Higuchi Y, Okunushi R, Hara T, Hashiguchi A, Yuan J, Yoshimura A, Murayama K, Ohtake A, Ando M, Hiramatsu Y, Ishihara S, Tanabe H, Okamoto Y, Matsuura E, Ueda T, Toda T, Yamashita S, Yamada K, Koide T, Yaguchi H, Mitsui J, Ishiura H, Yoshimura J, Doi K, Morishita S, Sato K, Nakagawa M, Yamaguchi M, Tsuji S, Takashima H.

Brain. 2018 Jun 1;141(6):1622-1636. doi: 10.1093/brain/awy104.

25.

Spred1 Safeguards Hematopoietic Homeostasis against Diet-Induced Systemic Stress.

Tadokoro Y, Hoshii T, Yamazaki S, Eto K, Ema H, Kobayashi M, Ueno M, Ohta K, Arai Y, Hara E, Harada K, Oshima M, Oshima H, Arai F, Yoshimura A, Nakauchi H, Hirao A.

Cell Stem Cell. 2018 May 3;22(5):713-725.e8. doi: 10.1016/j.stem.2018.04.002. Epub 2018 Apr 26.

PMID:
29706577
26.

A novel orange-colored bimolecular fluorescence complementation (BiFC) assay using monomeric Kusabira-Orange protein.

Fujii Y, Yoshimura A, Kodama Y.

Biotechniques. 2018 Apr;64(4):153-161. doi: 10.2144/btn-2017-0121.

27.

Oxidative cycloaddition of hydroxamic acids with dienes or guaiacols mediated by iodine(III) reagents.

Shimizu H, Yoshimura A, Noguchi K, Nemykin VN, Zhdankin VV, Saito A.

Beilstein J Org Chem. 2018 Feb 28;14:531-536. doi: 10.3762/bjoc.14.39. eCollection 2018.

28.

Assessing residual cancer cells using MRI and US after preoperative chemotherapy in primary breast cancer to omit surgery.

Iwase M, Sawaki M, Hattori M, Yoshimura A, Ishiguro J, Kotani H, Gondo N, Adachi Y, Kataoka A, Onishi S, Sugino K, Iwata H.

Breast Cancer. 2018 Apr 4. doi: 10.1007/s12282-018-0856-6. [Epub ahead of print]

PMID:
29619758
29.

Cholesterol-Induced Formation of Liquid Ordered Phase-Like Structures in Non-Phospholipid Systems.

Konno Y, Yoshimura A, Naito N, Aramaki K.

J Oleo Sci. 2018;67(4):419-426. doi: 10.5650/jos.ess17069.

30.

Myosin 1b promotes axon formation by regulating actin wave propagation and growth cone dynamics.

Iuliano O, Yoshimura A, Prospéri MT, Martin R, Knölker HJ, Coudrier E.

J Cell Biol. 2018 Jun 4;217(6):2033-2046. doi: 10.1083/jcb.201703205. Epub 2018 Mar 27.

PMID:
29588377
31.

Inhibition of Nr4a Receptors Enhances Antitumor Immunity by Breaking Treg-Mediated Immune Tolerance.

Hibino S, Chikuma S, Kondo T, Ito M, Nakatsukasa H, Omata-Mise S, Yoshimura A.

Cancer Res. 2018 Jun 1;78(11):3027-3040. doi: 10.1158/0008-5472.CAN-17-3102. Epub 2018 Mar 20.

PMID:
29559474
32.

Comparison of sentinel lymph node biopsy between invasive lobular carcinoma and invasive ductal carcinoma.

Adachi Y, Sawaki M, Hattori M, Yoshimura A, Gondo N, Kotani H, Iwase M, Kataoka A, Onishi S, Sugino K, Terada M, Horisawa N, Mori M, Oze I, Iwata H.

Breast Cancer. 2018 Mar 13. doi: 10.1007/s12282-018-0852-x. [Epub ahead of print]

PMID:
29536376
33.

Feasibility study of contralateral risk-reducing mastectomy with breast reconstruction for breast cancer patients with BRCA mutations in Japan.

Yoshimura A, Okumura S, Sawaki M, Hattori M, Ishiguro J, Adachi Y, Kotani H, Gondo N, Kataoka A, Iwase M, Onishi S, Sugino K, Terada M, Horisawa N, Mori M, Takaiso N, Hyodo I, Iwata H.

Breast Cancer. 2018 Mar 8. doi: 10.1007/s12282-018-0850-z. [Epub ahead of print]

PMID:
29520501
34.

Rice leaf hydrophobicity and gas films are conferred by a wax synthesis gene (LGF1) and contribute to flood tolerance.

Kurokawa Y, Nagai K, Huan PD, Shimazaki K, Qu H, Mori Y, Toda Y, Kuroha T, Hayashi N, Aiga S, Itoh JI, Yoshimura A, Sasaki-Sekimoto Y, Ohta H, Shimojima M, Malik AI, Pedersen O, Colmer TD, Ashikari M.

New Phytol. 2018 Jun;218(4):1558-1569. doi: 10.1111/nph.15070. Epub 2018 Mar 2.

PMID:
29498045
35.

Recent Improvement in the Long-term Survival of Breast Cancer Patients by Age and Stage in Japan.

Yoshimura A, Ito H, Nishino Y, Hattori M, Matsuda T, Miyashiro I, Nakayama T, Iwata H, Matsuo K, Tanaka H, Ito Y.

J Epidemiol. 2018 Feb 24. doi: 10.2188/jea.JE20170103. [Epub ahead of print]

36.

Ileo-ileal fistula with severe malnutrition caused by strangulated ileus surgery while preserving ischemic ileum: A case report.

Nishiwada S, Nakamura S, Tanaka T, Kirihataya Y, Nezu D, Sawa N, Fujita N, Ikegami H, Yoshimura A.

Int J Surg Case Rep. 2018;43:4-8. doi: 10.1016/j.ijscr.2018.01.008. Epub 2018 Jan 28.

37.

Canine case of swallowing syncope that improved after pacemaker implantation.

Fukushima R, Araie T, Itou N, Kawaguchi T, Yamada S, Yoshimura A, Goya S, Shimada K, Uchide T, Kishimoto M, Machida N.

J Vet Med Sci. 2018 Mar 24;80(3):460-464. doi: 10.1292/jvms.17-0451. Epub 2018 Feb 5.

38.

Clinical and genetic features of Charcot-Marie-Tooth disease 2F and hereditary motor neuropathy 2B in Japan.

Tanabe H, Higuchi Y, Yuan JH, Hashiguchi A, Yoshimura A, Ishihara S, Nozuma S, Okamoto Y, Matsuura E, Ishiura H, Mitsui J, Takashima R, Kokubun N, Maeda K, Asano Y, Sunami Y, Kono Y, Ishigaki Y, Yanamoto S, Fukae J, Kida H, Morita M, Tsuji S, Takashima H.

J Peripher Nerv Syst. 2018 Mar;23(1):40-48. doi: 10.1111/jns.12252. Epub 2018 Feb 14.

39.

STAT3 expression by myeloid cells is detrimental for the T- cell-mediated control of infection with Mycobacterium tuberculosis.

Gao Y, Basile JI, Classon C, Gavier-Widen D, Yoshimura A, Carow B, Rottenberg ME.

PLoS Pathog. 2018 Jan 16;14(1):e1006809. doi: 10.1371/journal.ppat.1006809. eCollection 2018 Jan.

40.

First-principles simulation of local response in transition metal dichalcogenides under electron irradiation.

Yoshimura A, Lamparski M, Kharche N, Meunier V.

Nanoscale. 2018 Feb 1;10(5):2388-2397. doi: 10.1039/c7nr07024a.

PMID:
29334100
41.

Clinical and mutational spectrum of Japanese patients with recessive variants in SH3TC2.

Yuan JH, Hashiguchi A, Okamoto Y, Yoshimura A, Ando M, Shiomi K, Saito K, Takahashi M, Ichinose K, Ohmichi T, Ichikawa K, Tadashi A, Takigawa H, Shibayama H, Takashima H.

J Hum Genet. 2018 Mar;63(3):281-287. doi: 10.1038/s10038-017-0388-5. Epub 2018 Jan 10.

PMID:
29321516
42.

Classification of C2C12 cells at differentiation by convolutional neural network of deep learning using phase contrast images.

Niioka H, Asatani S, Yoshimura A, Ohigashi H, Tagawa S, Miyake J.

Hum Cell. 2018 Jan;31(1):87-93. doi: 10.1007/s13577-017-0191-9. Epub 2017 Dec 13.

PMID:
29235053
43.

Collision skin lesions-results of a multicenter study of the International Dermoscopy Society (IDS).

Blum A, Siggs G, Marghoob AA, Kreusch J, Cabo H, Campos-do-Carmo G, Shiraishi AFC, Kienitz A, Maldonado-Seral C, Maltagliati-Holzner P, Mijuskovic ZP, Yoshimura AM, Moscarella E, Rabinovitz HS, Rodriguez-Garcia C, Saa SR, Rubegni P, Savoia F, Simionescu O, Diego PZ, Hofmann-Wellenhof R.

Dermatol Pract Concept. 2017 Jul 31;7(4):51-62. doi: 10.5826/dpc.0704a12. eCollection 2017 Oct.

44.

The Sox2 promoter-driven CD63-GFP transgenic rat model allows tracking of neural stem cell-derived extracellular vesicles.

Yoshimura A, Adachi N, Matsuno H, Kawamata M, Yoshioka Y, Kikuchi H, Odaka H, Numakawa T, Kunugi H, Ochiya T, Tamai Y.

Dis Model Mech. 2018 Jan 30;11(1). pii: dmm028779. doi: 10.1242/dmm.028779.

45.

Site-level progression of periodontal disease during a follow-up period.

Nomura Y, Morozumi T, Nakagawa T, Sugaya T, Kawanami M, Suzuki F, Takahashi K, Abe Y, Sato S, Makino-Oi A, Saito A, Takano S, Minabe M, Nakayama Y, Ogata Y, Kobayashi H, Izumi Y, Sugano N, Ito K, Sekino S, Numabe Y, Fukaya C, Yoshinari N, Fukuda M, Noguchi T, Kono T, Umeda M, Fujise O, Nishimura F, Yoshimura A, Hara Y, Nakamura T, Noguchi K, Kakuta E, Hanada N, Takashiba S, Amitani Y, Yoshie H.

PLoS One. 2017 Dec 4;12(12):e0188670. doi: 10.1371/journal.pone.0188670. eCollection 2017.

46.

Effects of minodronate in postmenopausal women with osteoporosis who received prior treatment with raloxifene.

Toda A, Sawada K, Yoshimura A, Nakatsuka E, Kuroda H, Kozasa K, Miyamoto M, Hashimoto K, Mabuchi S, Kimura T.

Int J Womens Health. 2017 Nov 13;9:821-825. doi: 10.2147/IJWH.S145805. eCollection 2017.

47.

Suppressor of Cytokine Signaling 3 in Macrophages Prevents Exacerbated Interleukin-6-Dependent Arginase-1 Activity and Early Permissiveness to Experimental Tuberculosis.

Schmok E, Abad Dar M, Behrends J, Erdmann H, Rückerl D, Endermann T, Heitmann L, Hessmann M, Yoshimura A, Rose-John S, Scheller J, Schaible UE, Ehlers S, Lang R, Hölscher C.

Front Immunol. 2017 Nov 10;8:1537. doi: 10.3389/fimmu.2017.01537. eCollection 2017.

48.

Plasminogen activator inhibitor-1 is an independent prognostic factor of ovarian cancer and IMD-4482, a novel plasminogen activator inhibitor-1 inhibitor, inhibits ovarian cancer peritoneal dissemination.

Nakatsuka E, Sawada K, Nakamura K, Yoshimura A, Kinose Y, Kodama M, Hashimoto K, Mabuchi S, Makino H, Morii E, Yamaguchi Y, Yanase T, Itai A, Morishige KI, Kimura T.

Oncotarget. 2017 Sep 12;8(52):89887-89902. doi: 10.18632/oncotarget.20834. eCollection 2017 Oct 27.

49.

Crystalline structure of pulverized dental calculus induces cell death in oral epithelial cells.

Ziauddin SM, Yoshimura A, Montenegro Raudales JL, Ozaki Y, Higuchi K, Ukai T, Kaneko T, Miyazaki T, Latz E, Hara Y.

J Periodontal Res. 2018 Jun;53(3):353-361. doi: 10.1111/jre.12520. Epub 2017 Nov 20.

PMID:
29159877
50.

Correction to: Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study.

Hattori M, Ishiguro H, Masuda N, Yoshimura A, Ohtani S, Yasojima H, Morita S, Ohno S, Iwata H.

Breast Cancer. 2018 Jan;25(1):126. doi: 10.1007/s12282-017-0815-7.

Supplemental Content

Loading ...
Support Center